FDA’s CRLs reveal critical errors in AstraZeneca’s Saphnelo data, efficacy doubts for GSK’s Exdensur
The FDA is providing more insight into the rejections it recently handed two pharma giants, publishing the complete response letters (CRLs) sent to AstraZeneca and GSK that highlight shortfalls in the ...
Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to ...
The Magnificent Seven represent 33.3% of the S&P 500 as of March 2026, up from 12.5% in 2016. From 2016 through 2025, these seven companies achieved an 875.5% return, outperforming the S&P 500. The ...
John Navin is a freelance writer for Investopedia. His stock-trading work was profiled in "The Warren Buffetts Next Door: The World's Greatest Investors You've Never Heard Of." Bloomberg/Getty Images ...
Tired of Microsoft Edge "Script Error" crashing your browsing on high-traffic websites? Get step-by-step fixes, causes, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results